Skip to content

Methodological Framework

This page describes the methodological framework of the BioRemPP Web Service: a KO-based, compound-centric approach for exploratory functional inference of bioremediation potential from genomic and metagenomic annotations.

Purpose and Scope

BioRemPP supports systematic interpretation of functional annotations in bioremediation-oriented studies by integrating standardized identifiers with curated knowledge resources.

BioRemPP is a research-only, exploratory framework intended for:

  • hypothesis generation and candidate prioritization;
  • comparative functional profiling across samples, datasets, and knowledge sources;
  • transparent, reproducible mapping between functional identifiers and bioremediation-relevant contexts.

BioRemPP is not intended for regulatory compliance determinations, clinical or risk-based decision-making, prediction of degradation kinetics, or operational field recommendations without independent experimental validation.

Scope and Limitations

BioRemPP provides exploratory functional inference of bioremediation potential based on genetic annotations. Results represent genetic capacity, not confirmed biological activity, gene expression, or degradation rates.

Critical boundaries:

  • Genetic potential ≠ biological activity
  • No kinetic modeling or expression weighting
  • Computational predictions require experimental validation
  • Not suitable for regulatory compliance or clinical decisions

For complete documentation of scope boundaries, methodological constraints, interpretation guidelines, and usage restrictions, see Limitations and Scope Boundaries.

Conceptual Analytical Model

KO as a standardized functional language

BioRemPP uses KEGG Orthology (KO) identifiers as a phylogeny-independent functional representation of samples. KO identifiers provide a stable, interoperable unit of analysis across genomes, metagenomes, MAGs, isolates, and transcriptome-derived annotations.

Compound-centric functional reasoning

BioRemPP adopts a compound-centric perspective that links functional identifiers to regulatory context:

KO identifiers → enzymatic function → mapped compounds → pathway context → toxicity/regulatory context

This abstraction enables questions such as:

  • which pollutant compounds are functionally addressable given observed enzyme orthologs;
  • whether inferred functional coverage aligns with known compound classes and degradation contexts;
  • how toxicological and regulatory metadata can support prioritization (not certification).

High-level Methodological Stages

BioRemPP’s framework can be understood as three methodological stages.

Stage 1 — Input abstraction

User inputs are treated as sets of KO identifiers per sample, representing functional annotations generated upstream. BioRemPP does not perform assembly, gene calling, or functional annotation.

Stage 2 — Deterministic knowledge integration

KO sets are mapped to curated reference knowledge using exact identifier matching and deterministic joins. The mapping is designed to preserve sample-level traceability across all derived tables and summaries.

Stage 3 — Independent analytical units

Analyses are organized into independent use cases grouped into thematic modules. Each use case addresses a distinct scientific question (e.g., coverage, similarity, enrichment, completeness, relationships), and can be interpreted and reported independently.

Representative Analytical Concepts

BioRemPP applies recurring analytical concepts across modules. These concepts are illustrative, not an exhaustive inventory.

  • KO Richness: characterization of samples by the diversity and composition of detected KO groups.
  • Compound coverage: characterization of samples by the breadth of mapped compounds associated with detected enzymatic functions.
  • Similarity and complementarity: assessment of overlap versus complementarity across samples based on shared KO and compound profiles.
  • Pathway-oriented completeness (contextual): approximation of coverage of multi-step functional routes based on presence/absence of required functional units.
  • System-level organization: identification of recurring functional patterns (e.g., guild-like clusters) emerging from shared functional/chemical profiles.

Interpretation Boundaries

Genetic potential vs biological activity

BioRemPP outputs represent functional potential inferred from annotations. Presence of a KO identifier does not demonstrate:

  • transcription, translation, or regulation under the studied conditions;
  • enzyme activity, substrate availability, or environmental feasibility;
  • net conversion of pollutants or measurable remediation outcomes.

Interpret results as candidate evidence to guide downstream validation and experimental design.

Toxicology and regulatory metadata are contextual

Toxicological predictions and regulatory classifications are provided for informational context and prioritization. They do not constitute:

  • legal compliance judgments;
  • formal risk assessments;
  • exposure limit or hazard determinations;
  • regulatory approval or certification.

Reproducibility Principles

BioRemPP is designed to support reproducible scientific reporting through:

  • Versioned knowledge resources: curated data snapshots aligned with service releases.
  • Deterministic mapping: exact identifier-based integration with no probabilistic assignments.
  • Transparent, declarative analysis definitions: analyses are parameterized and version-controlled to enable independent inspection and replication.

This page intentionally remains high-level and non-operational. For detailed methodological components, see: